Methods for analysis of the cancer microenvironment and their potential for disease prediction, monitoring and personalized treatments

EPMA Journal

Volumn 3, Issue 1, 2012, Pages

  Clausson, Carl Magnus ^a   Grundberg, Ida ^a   Weibrecht, Irene ^a   Nilsson, Mats ^a   Söderberg, Ola ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

Diagnosis; Padlock probes; Personalized medicine; PLA; Prognosis; Tumor microenvironment

Indexed keywords

ANTIGEN; COMPLEMENTARY DNA; GENOMIC DNA; LOCKED NUCLEIC ACID; MESSENGER RNA; MITOCHONDRIAL DNA; OLIGONUCLEOTIDE;

ANTIGEN BINDING; CANCER CELL; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER GROWTH; CANCER INHIBITION; CANCER PROGNOSIS; CELL ACTIVITY; CELL COMMUNICATION; CELL DEATH; CELL FATE; CELL SURVIVAL; CIRCULATING TUMOR CELL; DNA PROBE; DNA SEQUENCE; EPIGENETICS; EPITHELIAL MESENCHYMAL TRANSITION; FLUORESCENCE IN SITU HYBRIDIZATION; FLUORESCENCE RESONANCE ENERGY TRANSFER; GENOTYPE; HETEROZYGOSITY LOSS; HYPOXIA; IMMUNOHISTOCHEMISTRY; MALIGNANT NEOPLASTIC DISEASE; MESENCHYMAL STEM CELL; NONHUMAN; NUCLEIC ACID ANALYSIS; PADLOCK PROBE; PATHOPHYSIOLOGY; PERSONALIZED MEDICINE; PREVALENCE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; PROTEIN NUCLEIC ACID INTERACTION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; REVIEW; RNA ANALYSIS; SIGNAL TRANSDUCTION; TERATOMA; TUMOR MICROENVIRONMENT; TUMOR VASCULARIZATION; CANCER TISSUE; GENE EXPRESSION REGULATION; GENOTYPING TECHNIQUE; HUMAN; INTRACELLULAR SIGNALING; PATIENT MONITORING; PHENOTYPE; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR PROMOTION;

EID: 84870486012     PISSN: 18785077     EISSN: 18785085     Source Type: Journal    
DOI: 10.1007/s13167-012-0140-3     Document Type: Review

References (57)

1. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, et al. Genetic alterations during colorectal-tumor development. N Engl J Med 1988, 319(9):525-32. 10.1056/NEJM198809013190901, 2841597.
2. Sjöblom T, Jones S, Wood LD, Parsons DW, Lin J, Barber TD, et al. The consensus coding sequences of human breast and colorectal cancers. Science 2006, 314(5797):268-74. 10.1126/science.1133427, 16959974.
3. Feinberg AP, Ohlsson R, Henikoff S. The epigenetic progenitor origin of human cancer. Nat Rev Genet 2006, 7(1):21-33. 10.1038/nrg1748, 16369569.
4. Illmensee K, Mintz B. Totipotency and normal differentiation of single teratocarcinoma cells cloned by injection into blastocysts. Proc Natl Acad Sci USA 1976, 73(2):549-53. 10.1073/pnas.73.2.549, 335947, 1061157.
5. Mintz B, Illmensee K. Normal genetically mosaic mice produced from malignant teratocarcinoma cells. Proc Natl Acad Sci USA 1975, 72(9):3585-9. 10.1073/pnas.72.9.3585, 433040, 1059147.
6. Hentze H, Soong PL, Wang ST, Phillips BW, Putti TC, Dunn NR. Teratoma formation by human embryonic stem cells: Evaluation of essential parameters for future safety studies. Stem Cell Res 2009,
7. Lensch MW, Schlaeger TM, Zon LI, Daley GQ. Teratoma formation assays with human embryonic stem cells: a rationale for one type of human-animal chimera. Cell Stem Cell 2007, 1(3):253-8. 10.1016/j.stem.2007.07.019, 18371359.
8. Müller FJ, Goldmann J, Löser P, Loring JF. A call to standardize teratoma assays used to define human pluripotent cell lines. Cell Stem Cell 2010, 6(5):412-4. 10.1016/j.stem.2010.04.009, 20452314.
9. Bissell MJ, Hines WC. Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression. Nat Med 2011, 17(3):320-9. 10.1038/nm.2328, 21383745.
10. Rich AR. On the frequency of occurrence of occult carcinoma of the prostrate. 1934. Int J Epidemiol 2007, 36(2):274-7. 10.1093/ije/dym050, 17567641.
11. Sakr W, Haas G, Cassin B, Pontes J, Crissman J. The frequency of carcinoma and intraepithelial neoplasia of the prostate in young male patients. J Urol 1993, 150(2 Pt 1):379.
12. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011, 144(5):646-74. 10.1016/j.cell.2011.02.013, 21376230.
13. Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell 2010, 140(6):883-99. 10.1016/j.cell.2010.01.025, 2866629, 20303878.
14. Kroemer G, Pouyssegur J. Tumor cell metabolism: cancer's Achilles' heel. Cancer Cell 2008, 13(6):472-82. 10.1016/j.ccr.2008.05.005, 18538731.
15. Liguori M, Solinas G, Germano G, Mantovani A, Allavena P. Tumor-associated macrophages as incessant builders and destroyers of the cancer stroma. Cancers 2011, 3(4):3740-61.
16. Schäfer M, Werner S. Cancer as an overhealing wound: an old hypothesis revisited. Nat Rev Mol Cell Biol 2008, 9(8):628-38. 10.1038/nrm2455, 18628784.
17. Potente M, Gerhardt H, Carmeliet P. Basic and therapeutic aspects of angiogenesis. Cell 2011, 146(6):873-87. 10.1016/j.cell.2011.08.039, 21925313.
18. Comen E, Norton L, Massague J. Clinical implications of cancer self-seeding. Nat Rev Clin Oncol 2011, 8(6):369-77.
19. Huh SJ, Liang S, Sharma A, Dong C, Robertson GP. Transiently entrapped circulating tumor cells interact with neutrophils to facilitate lung metastasis development. Cancer Research 2010, 70(14):6071-82. 10.1158/0008-5472.CAN-09-4442, 2905495, 20610626.
20. Chen Q, Zhang XH, Massague J. Macrophage binding to receptor VCAM-1 transmits survival signals in breast cancer cells that invade the lungs. Cancer Cell 2011, 20(4):538-49. 10.1016/j.ccr.2011.08.025, 22014578.
21. Ferrara N. Pathways mediating VEGF-independent tumor angiogenesis. Cytokine Growth Factor Rev 2010, 21(1):21-6. 10.1016/j.cytogfr.2009.11.003, 20005148.
22. Bhowmick NA, Neilson EG, Moses HL. Stromal fibroblasts in cancer initiation and progression. Nature 2004, 432(7015):332. 10.1038/nature03096, 3050735, 15549095.
23. Klopp AH, Gupta A, Spaeth E, Andreeff M, Marini F. Concise review: dissecting a discrepancy in the literature: do mesenchymal stem cells support or suppress tumor growth?. Stem Cells 2011, 29(1):11-9. 10.1002/stem.559, 3059412, 21280155.
24. Takebe N, Ivy SP. Controversies in cancer stem cells: targeting embryonic signaling pathways. Clin Cancer Res 2010, 16(12):3106-12. 10.1158/1078-0432.CCR-09-2934, 20530695.
25. Visvader JE, Lindeman GJ. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer 2008, 8(10):755-68. 10.1038/nrc2499, 18784658.
26. Yang MH, Wu MZ, Chiou SH, Chen PM, Chang SY, Liu CJ, et al. Direct regulation of TWIST by HIF-1alpha promotes metastasis. Nat Cell Biol 2008, 10(3):295-305. 10.1038/ncb1691, 18297062.
27. Wu MZ, Tsai YP, Yang MH, Huang CH, Chang SY, Chang CC, et al. Interplay between HDAC3 and WDR5 is essential for hypoxiainduced epithelial-mesenchymal transition. Mol Cell 2011, 43(5):811-22. 10.1016/j.molcel.2011.07.012, 21884981.
28. Daniel VC, Marchionni L, Hierman JS, Rhodes JT, Devereux WL, Rudin CM, et al. A primary xenograft model of small-cell lung cancer reveals irreversible changes in gene expression imposed by culture in vitro. Cancer Res 2009, 69(8):3364-73. 10.1158/0008-5472.CAN-08-4210, 2821899, 19351829.
29. Li A, Walling J, Kotliarov Y, Center A, Steed ME, Ahn SJ, et al. Genomic changes and gene expression profiles reveal that established glioma cell lines are poorly representative of primary human gliomas. Mol Cancer Res 2008, 6(1):21-30. 10.1158/1541-7786.MCR-07-0280, 18184972.
30. Bauman JGJ, Wiegant J, Borst P, van Duijn P. A new method for fluorescence microscopical localization of specific DNA sequences by in situ hybridization of fluorochrome-labelled RNA. Exp Cell Res 1980, 128(2):485-90. 10.1016/0014-4827(80)90087-7, 6157553.
31. Nilsson M, Malmgren H, Samiotaki M, Kwiatkowski M, Chowdhary BP, Landegren U. Padlock probes: circularizing oligonucleotides for localized DNA detection. Science 1994, 265(5181):2085-8. 10.1126/science.7522346, 7522346.
32. Nilsson M, Krejci K, Koch J, Kwiatkowski M, Gustavsson P, Landegren U. Padlock probes reveal single-nucleotide differences, parent of origin and in situ distribution of centromeric sequences in human chromosomes 13 and 21. Nat Genet 1997, 16(3):252-5. 10.1038/ng0797-252, 9207789.
33. Lizardi PM, Huang X, Zhu Z, Bray-Ward P, Thomas DC, Ward DC. Mutation detection and single-molecule counting using isothermal rolling-circle amplification. Nat Genet 1998, 19(3):225-32. 10.1038/898, 9662393.
34. Blab GA, Schmidt T, Nilsson M. Homogeneous detection of single rolling circle replication products. Anal Chem 2004, 76(2):495-8. 10.1021/ac034987+, 14719904.
35. Larsson C, Koch J, Nygren A, Janssen G, Raap AK, Landegren U, et al. In situ genotyping individual DNA molecules by target-primed rolling-circle amplification of padlock probes. Nat Methods 2004, 1(3):227-32. 10.1038/nmeth723, 15782198.
36. Nilsson M, Barbany G, Antson DO, Gertow K, Landegren U. Enhanced detection and distinction of RNA by enzymatic probe ligation. Nat Biotechnol 2000, 18(7):791-3. 10.1038/77367, 10888852.
37. Nilsson M, Landegren U, Antson DO. Single-nucleotide sequence discrimination in situ using padlock probes. Curr Protoc Cytom 2001, Chapter 8. Unit 8.8.
38. Larsson C, Grundberg I, Söderberg O, Nilsson M. In situ detection and genotyping of individual mRNA molecules. Nat Methods 2010, 7(5):395-7. 10.1038/nmeth.1448, 20383134.
39. Silahtaroglu A, Pfundheller H, Koshkin A, Tommerup N, Kauppinen S. LNA-modified oligonucleotides are highly efficient as FISH probes. Cytogenet Genome Res 2004, 107(1-2):32-7. 10.1159/000079569, 15305054.
40. Silahtaroglu AN, Tommerup N, Vissing H. FISHing with locked nucleic acids (LNA): evaluation of different LNA/DNA mixmers. Mol Cell Probes 2003, 17(4):165-9. 10.1016/S0890-8508(03)00048-3, 12944118.
41. Kurreck J, Wyszko E, Gillen C, Erdmann VA. Design of antisense oligonucleotides stabilized by locked nucleic acids. Nucleic Acids Res 2002, 30(9):1911-8. 10.1093/nar/30.9.1911, 113840, 11972327.
42. Schermelleh L, Heintzmann R, Leonhardt H. A guide to superresolution fluorescence microscopy. J Cell Biol 2010, 190(2):165-75. 10.1083/jcb.201002018, 2918923, 20643879.
43. Selvin PR. The renaissance of fluorescence resonance energy transfer. Nat Struct Biol 2000, 7(9):730-4. 10.1038/78948, 10966639.
44. Berezovska O, Ramdya P, Skoch J, Wolfe MS, Bacskai BJ, Hyman BT. Amyloid precursor protein associates with a nicastrin-dependent docking site on the presenilin 1-gamma-secretase complex in cells demonstrated by fluorescence lifetime imaging. J Neuroscience 2003, 23(11):4560-6.
45. Jones PB, Rozkalne A, Meyer-Luehmann M, Spires-Jones TL, Makarova A, Kumar ATN, et al. Two postprocessing techniques for the elimination of background autofluorescence for fluorescence lifetime imaging microscopy. J Biomed Opt 2008, 13:014008. 10.1117/1.2837169, 18315366.
46. Söderberg O, Gullberg M, Jarvius M, Ridderstråle K, Leuchowius KJ, Jarvius J, et al. Direct observation of individual endogenous protein complexes in situ by proximity ligation. Nat Methods 2006, 3(12):995-1000. 10.1038/nmeth947, 17072308.
47. Baan B, Pardali E, ten Dijke P, van Dam H. In situ proximity ligation detection of c-Jun/AP-1 dimers reveals increased levels of c-Jun/Fra1 complexes in aggressive breast cancer cell lines in vitro and in vivo. Mol Cell Proteomics 2010, 9(9):1982. 10.1074/mcp.M110.000943, 2938117, 20511396.
48. Jarvius M, Paulsson J, Weibrecht I, Leuchowius KJ, Andersson AC, Wählby C, et al. In situ detection of phosphorylated platelet-derived growth factor receptor β using a generalized proximity ligation method. Mol Cell Proteomics 2007, 6(9):1500. 10.1074/mcp.M700166-MCP200, 17565975.
49. Conze T, Carvalho AS, Landegren U, Almeida R, Reis CA, David L, et al. MUC2 mucin is a major carrier of the cancer-associated sialyl-Tn antigen in intestinal metaplasia and gastric carcinomas. Glycobiology 2010, 20(2):199. 10.1093/glycob/cwp161, 19815850.
50. Zieba A, Wählby C, Hjelm F, Jordan L, Berg J, Landegren U, et al. Bright-field microscopy visualization of proteins and protein complexes by in situ proximity ligation with peroxidase detection. Clin Chem 2010, 56(1):99-110. 10.1373/clinchem.2009.134452, 19926775.
51. Clausson CM, Allalou A, Weibrecht I, Mahmoudi S, Farnebo M, Landegren U, et al. Increasing the dynamic range of in situ PLA. Nat Methods 2011, 8(11):892-3. 10.1038/nmeth.1743, 22036742.
52. Zirbel R, Mathieu U, Kurz A, Cremer T, Lichter P. Evidence for a nuclear compartment of transcription and splicing located at chromosome domain boundaries. Chromosome Res 1993, 1(2):93-106. 10.1007/BF00710032, 8143096.
53. Brown K. Visualizing nuclear proteins together with transcribed and inactive genes in structurally preserved cells. Methods 2002, 26(1):10-8. 10.1016/S1046-2023(02)00003-8, 12054900.
54. Brown KE, Guest SS, Smale ST, Hahm K, Merkenschlager M, Fisher AG. Association of transcriptionally silent genes with Ikaros complexes at centromeric heterochromatin. Cell 1997, 91(6):845-54. 10.1016/S0092-8674(00)80472-9, 9413993.
55. Weibrecht I, Gavrilovic M, Lindbom L, Landegren U, Wählby C, Söderberg O. Visualising individual sequence-specific protein-DNA interactions in situ. N Biotechnol doi:10.1016/j.nbt.2011.08.002.
56. Leuchowius KJ, Jarvius M, Wickström M, Rickardson L, Landegren U, Larsson R, et al. High content screening for inhibitors of protein interactions and post-translational modifications in primary cells by proximity ligation. Mol Cell Proteomics 2010, 9(1):178-83. 10.1074/mcp.M900331-MCP200, 2808263, 19864249.
57. Weibrecht I, Grundberg I, Nilsson M, Söderberg O. Simultaneous visualization of both signaling cascade activity and end-point gene expression in single cells. PLoS One 2011, 6(5):e20148. 10.1371/journal.pone.0020148, 3102075, 21647446.